Anti-Idiotype Monoclonal Antibodies as Vaccines for Human Cancer
- 1 January 1991
- journal article
- review article
- Published by Taylor & Francis in International Reviews of Immunology
- Vol. 7 (4), 289-302
- https://doi.org/10.3109/08830189109114876
Abstract
The anti-idiotype therapy approach has been tested and has shown to be effective in several animal models including the L1210/GZL tumor system in DBA/2 mice. Very recently, anti-idiotype antibodies (Ab2) have also been used in human trials. In this review, the generation and characterization of Ab2s which can be used as potential vaccine candidates for two human tumor systems-leukemia/lymphona and gastrointestinal carcinoma have been discussed. We have generated syngeneic monoclonal idiotypic cascades for two different human tumor-associated antigens (TAA) gp37 and carcinoembryonic antigen (CEA). In both cascades we have produced TAA mimicking monoclonal Ab2s and monoclonal anti-anti-idiotypes (Ab3) which bind to the original TAA. Modulation of immune responses in cancer patients by Ab2 immunization will be an important consideration in future studies.Keywords
This publication has 20 references indexed in Scilit:
- Revised immune network conceptsClinical Immunology and Immunopathology, 1989
- Anti-idiotypic Antibody Vaccine for Type B Viral Hepatitis in ChimpanzeesScience, 1986
- Anti-Idiotypic Antibodies of Reovirus as Biochemical and Immunological MimicsInternational Reviews of Immunology, 1986
- Monoclonal Idiotope Vaccine Against Streptococcus pneumoniae InfectionScience, 1984
- Neonatal administration of idiotype or antiidiotype primes for protection against Escherichia coli K13 infection in mice.The Journal of Experimental Medicine, 1984
- Immunization of mice against African trypanosomiasis using anti-idiotypic antibodies.The Journal of Experimental Medicine, 1982
- Implications of the presence of an internal image of the antigen in anti-idiotypic antibodies: Possible application to vaccine productionClinical Immunology and Immunopathology, 1981
- Idiotype-anti-idiotype regulation. I. Immunization with a levan-binding myeloma protein leads to the appearance of auto-anti-(anti-idiotype) antibodies and to the activation of silent clones.The Journal of Experimental Medicine, 1981
- A carcinoembryonic antigen (CEA) specific monoclonal hybridoma antibody that reacts only with high-molecular-weight CEACancer Immunology, Immunotherapy, 1980
- DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUESThe Journal of Experimental Medicine, 1965